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Abstract
Periprosthetic Joint Infection (PJI) is a devastating complication of the Total 
Joint Arthroplasty (TJA). It presents a great challenge for the clinician to diag-
nose and manage it appropriately, with significant morbidity for the patients and 
cost for health care providers. The purpose of this study is to review and examine 
the role of multi-disciplinary team (MDT) approach in diagnosis and manage-
ment of prosthetic joint infection (PJI) and how this approach can influence 
outcomes. All published literature examining the role of multidisciplinary care 
in the management of PJI and the influence of this approach to the management 
and outcomes of patients with this diagnosis were included. Studies published 
in languages other than English were excluded. There is a paucity of data on 
the influence of multidisciplinary care on outcomes of the management of PJI. 
Evidence suggests that the MDT has important role in ensuring all factors in 
the management of this complex group are considered and best possible care is 
delivered. Multicentre randomised clinical trials are required to assess the influ-
ence of MDT’S on outcome as well as important questions around the structuring 
of these teams.
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1. Introduction and background
Prosthetic joint infection (PJI) affects about 1–3% of patients undergoing total 
joint arthroplasty [1]. In some units the infection rate is reported to be as high 
as 5% [2]. It is one of the most devastating complications and poses significant 
challenges for the patient, health care providers and the treating institution. 
The financial cost of treating a single case of PJI can be as high as £100,000 [2]. 
Costs for patients are even higher, with long hospital stay, multiple operations, 
associated pain and suffering, reduced life quality as well as risks associated with 
surgical morbidity and mortality. Diagnosis and management of PJI remains con-
troversial and complex. There is no universal definition of the PJI. The definition 
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of PJI proposed by the International Consensus Meeting on Periprosthetic Joint 
Infection is the most universally accepted one [3]. Other definitions also exist. 
George et al. [4] acknowledged 7 definitions produced by various consensus 
meetings. This illustrates that PJI remains a debatable and controversial topic and 
diagnosis is not straight forward. There is no one single test that can adequately 
diagnose PJI. Up to 10% of cases undergoing revision for aseptic loosening are 
later found to have prosthetic joint infection [5]. PJI can present in variety of 
ways and at varying phases from the time primary arthroplasty implantation. 
Tsukayama et al. proposed a classification system that divided PJI into four 
categories [6].
It can be challenging for an individual surgeon to make an accurate diagnosis 
when faced with a patient with a painful arthroplasty. One way of addressing this 
has been to manage this complex group of patients with a multidisciplinary team. 
Failure to make a timely and accurate diagnosis can significantly compromise 
therapeutic options and have a negative impact on the result of surgical treatment 
[7]. Furthermore, if PJI is not recognised, it may lead to systemic symptoms such as 
bacteraemia and septicaemia.
PJI can be challenging to treat, and patients may need a number of major 
surgical procedures, coupled with antimicrobial treatment for several weeks to 
eradicate the infection [8]. Treatment of PJI of the knee may be associated with a 
long period of disability with possible immobilisation of the knee. This may lead 
to a poor functional outcome. Recurrence of the infection is high and reported 
between 8% and 70% [9] and complications associated with surgery are com-
mon. Furthermore, PJI is associated with significant mortality. Berend et al. [10] 
reported that 11% patients treated for PJI with a 2 stage regime died between the 
first and second stages of surgical treatment. Zmistowski et al. [3] found that the 
5-year survivorship of patients with PJI is worse than for some common cancers 
including breast cancer or testicular cancer. For this reason PJI must be man-
aged expeditiously, providing patients with all available expertise to achieve the 
optimum outcome. Added to this is the psychological burden associated with the 
issues described and its impact on post operative function [11]. This combination 
of the knowledge that there has been a complication or suboptimal outcome, 
multiple surgical procedures, prolonged hospital stay, prolonged disability and 
associated medical comorbidities as well as social isolation and pain illustrates 
multiple issues which can be associated with patients presenting with PJI and 
the multiple facets which require management in a synchronised manner. These 
factors have been acknowledged in other aspects of orthopaedic surgery and it is 
acknowledged that optimal outcomes result from a multidisciplinary approach to 
management [12, 13].
2. Treatment options for PJI
Debridement, Antibiotics and Implant Retention (DAIR): When infection is diag-
nosed early, open debridement and exchange of modular prosthetic components 
followed by prolonged antibiotic therapy may lead to satisfactory results. Retention 
of the implant leads to superior functional results in cases where the infection is 
eradicated [14].
Single stage revision: Exchange off all components of the arthroplasty (both fixed 
and modular) is coupled with radical debridement of the joint and antibiotic treat-
ment. Removal of all implants and reconstruction with new definitive prostheses. 
Single stage revision is usually performed in selected patients. The ideal patient is 
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a well host, with a healthy soft tissue envelope, absence of a draining sinus and a 
known sensitive microbe are commonly accepted prerequisites [15].
Two stage revision: Removal of all implants during one surgical procedure 
is performed. The joint is excised with or without placement of a temporary 
spacer. Antibiotics are delivered locally (with cement or other delivery modes) 
and systemically. Following a prolonged period of antibiotic treatment (6 weeks 
or more), when infection is deemed to be eradicated, re-implantation (the 
second stage) is performed. During the second stage procedure further debride-
ment takes place. The spacer is removed and the joint is reconstructed. The 
success rate is greater than of single stage revision procedure [10, 14]. The 
significant downside of this approach relates to the time between the 2 stages 
of the revision. During this time the patients’ mobility is poor, joint function 
is very limited, and the patient is often required to stay in health care facility. 
The risk of complications (renal failure, Clostridium difficile diarrhoea) and 
mortality are significant. The patient also undergoes two separate major surgical 
procedures.
Excision arthroplasty: This involves removal of all the implants and excision of 
the joint followed by a course of antibiotics. The function of the joint is severely 
compromised, and the patient suffers significant disability. This salvage mode of 
treatment is reserved for the most complex infections in compromised hosts, with 
severe bone loss, presence of poly-microbial infection and an unhealthy soft tissue 
envelope exist [16].
Amputation: When the infection is not manageable or becomes a threat to the 
patient’s life this might be the only option.
Prolonged suppressive antibiotic therapy (PSAT): In the presence of draining sinus 
and well-functioning joint, or when the host suffers from serious comorbidities that 
could preclude surgical intervention, antibiotic suppression may lead to satisfac-
tory results. The infection cannot be eradicated, but it does not manifest itself 
systematically and symptoms related to the affected joint may be manageable for 
the patient. The senior author has previously reported found that infection control 
could be achieved in selected cases of PJI using this approach [17]. The patients’ 
comorbidities and fitness for major surgery as well as psychological condition of the 
individual are also of incredible importance [18].
The physical, but also psychological needs of patients should be addressed. 
PJI may be emotionally difficult to cope with and lead to sequalae such as depres-
sion and anxiety [19]. Many patients struggle with the impact that the treatment 
of PJI has on their personal and family lives’. Patients’ depression may require 
treatment and support during the treatment as well as during the recovery 
phases [20].
3. The role of the MDT
Ideally personnel should be present in the same location in order to provide a 
seamless, clinically and cost-efficient service to patients with PJI. They should be 
involved in all stages of the management pathways including, diagnosis, treatment 
(both surgical and non-surgical) and long term follow up. The multidisciplinary 
approach has made a significant difference in care of oncology patients. Time 
to diagnosis and clinical outcomes have all been shown to improve when the 
MDT functions well well [21, 22]. There is no published evidence to the authors’ 
knowledge on the management of PJI with this approach however the principles of 
diagnosis and factors influencing management and outcomes of patients with PJI 
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are similar. It seems intuitive therefore that a similar approach to treatment might 
produce similar outcomes.
4. What comprises a multidisciplinary team?
Most published studies examining the benefits of MDT’s have focused on clinical 
results [22]. There is a relative paucity of data on the components of the MDT. An 
important principle of care delivery in this setting is consideration of the wholistic 
needs of the patient and including appropriate specialists to address these issues. In 
the context of PJI the following team members are required:
Orthopaedic Surgeon- The surgeon coordinates and orchestrates the care of the 
patient. They need to establish the diagnosis, identify the individuals required to 
care for the patient and coordinate meetings. They are required to have the neces-
sary skillset and to carry out the surgical treatment required. A minimum require-
ment would be fellowship training in revision arthroplasty surgery.
Microbiologist- A microbiologist is vital to the multidisciplinary team. With their 
expertise and specialist knowledge of microbial metabolism specific diagnostic 
requirements, mechanism of antibiotic function and interactions and the require-
ments for monitoring of these issues, their importance is non controversial. The role 
of musculoskeletal microbiology is rapidly evolving with developments in diagnosis 
such as 16 s polymerase chain reaction (16 s PCR) testing. This speciality has made 
significant contributions to the practical management of patients with PJI such as 
the OVIVA (Oral versus Intravenous Antibiotics for Bone and Joint Infection) trial 
[23]. A dedicated microbiology clinic also provides another medium for follow up 
and support of this complex group of patients.
Musculoskeletal Radiologist- Radiologists are central in the decision making 
process. This stage often requires judgement based on a variety of imaging modali-
ties. An experienced radiologist is invaluable in advising on the optimal imaging 
modality and interpreting subtle signs on imaging. In the experience of the authors 
this is one of the most useful and educational parts of the MDT meeting.
Nutritionist- Nutritionists contribute significantly to pre and post operative opti-
misation of the patient. Malnutrition and vitamin D deficiency have been shown 
to positively correlate with PJI [24]. Low serum albumin level and low lymphocyte 
count are at increased risk of infection, wound dehiscence and medical complica-
tions [25–27]. Cross et al. [26] postulated that normalisation of the serum albumin 
level and tight glucose control may lead to better outcomes in orthopaedic surgery. 
Management of these factors has an important role in reducing the risk of reinfec-
tion following revision surgery.
Physiotherapist- The ultimate aim of revision surgery is restoration of a pain free, 
mobile with restoration of function and activity. Pre and post operative physio-
therapy is vital to achieving these aims. Physical therapy has been shown to improve 
soft-tissue tension, joint range of motion, and muscle strength and can reduce pain 
and stiffness [28, 29].
Clinical Nursing Specialist (CNS)- The role of a dedicated nurse specialist care 
cannot be understated. Walker [30] acknowledged the vital role which nurses 
play in the management of patients undergoing joint replacement surgery. The 
multifaceted role of a CNS has also been described by Pertino et al. [31]. The 
nurse specialist has several key clinical and organisational roles including being 
the point of contact for referrals, organising investigations, coordinating care 
between multiple specialities when these are involved and being a point of contact 
for patients.
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5. Examples of multidisciplinary teams
At the authors’ institution, there is an established referral network for complex 
cases including those presenting with PJI. Clinicians from the region can refer 
any patient who needs complex arthroplasty assessment and treatment, including 
those with PJI to a centralised hub. There is a standardised referral proforma and 
MDT coordinator who promptly responds to all referrals. There is a weekly MDT 
attended by complex arthroplasty surgeons, a CNS and radiologists with an interest 
in musculoskeletal medicine. Cases are discussed and either advice is provided or 
a decision on transfer of the patient to the Hub Hospital is organised. In complex 
cases when surgery is required, surgical planning is performed and details such as 
surgical approach, instruments and required implants are all discussed. Each week 
between 10 to 20 cases are discussed. Advice of plastic surgeons, vascular surgeons 
and microbiologists is available on request. There is also a monthly MDT meeting 
attended by the same team of complex arthroplasty surgeons as well as microbiolo-
gists with an interest in bone and joint infection and outpatient antibiotic treatment 
(OPAT) team. All cases undergoing treatment for infection are discussed, plans for 
surgical and non-surgical treatment are established and progress of treated patients 
is discussed. This ensures that most appropriate treatment plan is made for each 
individual.
The East Midlands Specialist Orthopaedic Network (EMSON) (Nottingham, 
UK) was established and its success has been reported [32]. All referrals are received 
by email by the MDT coordinator. The meetings are conducted using secure vide-
olink, with complex arthroplasty surgeons from Nottingham University Hospital 
and microbiologists attending while consultants from neighbouring hospitals dial 
in to discuss challenging cases. During first 6 months 166 cases were discussed, 
43% of which the initial plan was amended as the result of the discussion. In several 
cases, there was a significant alteration to the treatment plan. Referring surgeons 
are also encouraged to come to tertiary centre with the potential for joint consultant 
operating. This improves the experience of all clinicians involved.
6. Why should we adopt a Multidisciplinary approach
The potential benefits of care delivered via a MDT approach can be experienced 
on a variety of levels:
The Unit level- The centre which provides this level of care will likely benefit 
from an increased volume of patients and referrals. This will the increase the 
experience gained by clinicians in dealing with his condition.
The clinician level- Individual clinicians will have improved exposure to a larger 
number of cases. This has the potential to improve technical proficiency. Clinicians 
will also be motivated to receive further training and broaden their knowledge in 
field of PJI. This will also improve their knowledge and level of expertise by partici-
pating in MDT discussions.
The patient level- Patients are more likely to receive coordinated, individual care 
by specialists with greatest level of expertise in the field of PJI.
7. Challenges to the establishment of a multidisciplinary team
The treatment of PJI is labour and resource intensive. Patients often stay on 
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complications that non-infected cases. It is likely that the number of referrals and 
number of treated patients will increase over time which increases this burden [32].
Vaneghan et al. have shown that the cost of surgical treatment is significantly 
higher than septic revisions [33]. There is a potential risk of rapid depletion of 
financial resources. Renumeration strategies need to be established prior to starting 
this type of service [18, 33].
The logistics and practical aspects of establishing a MDT requires careful atten-
tion to detail. An understanding of what is required on a practical level is important. 
Meetings of large numbers of specialists takes these services from other departments. 
To the authors’ knowledge there has been no definition of the optimal constituents a 
MDT or of the minimal number of specialists required or whether the teams involved 
in diagnostic and therapeutic parts of the patient journey should be different.
Job planning for all the members of the team should be coordinated to allow all 
members to meet or dial in to discuss cases. Surgeons, radiologists, microbiologists 
and other health care professionals involved in PJI management need to find time 
during their busy weekly schedule for MDT to work. Furthermore, when transfer of 
the patient is necessary to the specialist centre, logistical arrangements need to be in 
place to avoid delays.
Another unexplored aspect of delivering care in this way is the issue of respon-
sibility and autonomy. The MDT moves away from the heirarchical system in which 
decisions are made by one senior individual towards one where there is shared 
decision making. This raises the subject of accountability. When a decision is taken 
by a group, who is responsible and who, if anyone, is accountable when things go 
wrong? For the same reason there can be a perceived risk to the autonomy of the 
referring surgeon. These issues have not been addressed.
In conclusion the management of PJI is complex and multifactorial. 
Multidisciplinary management has resulted in improved clinical results in similar 
settings setting such as tumour surgery however establishment of  multidisciplinary 
care presents significant challenges to the treating institution.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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